ProShares Ultra Nasdaq Biotechnology Rating $66.67 +2.01 (+3.11%) Closing price 10/15/2025 03:59 PM EasternExtended Trading$66.68 +0.01 (+0.01%) As of 10/15/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.67Holdings in BIB have an aggregate rating of Moderate Buy based on 370 analyst ratings issued in the past year covering 19 companies (38.6% of the portfolio).BIB Aggregate Price Target$66.67High Prediction$66.67Average Prediction$66.67Low Prediction$66.67Holdings in BIB have an aggregate price target of $66.67 and a range of $66.67 to $66.67 covering 19 companies (38.6% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.05%AMGNAmgen$297.32+1.2%4.5309 of 5 stars2.35$309.42 4.1%20Positive NewsAnalyst Revision5.03%VRTXVertex Pharmaceuticals$407.90-1.0%4.7974 of 5 stars2.62$494.38 21.2%29Positive NewsAnalyst Revision4.86%GILDGilead Sciences$118.30-0.2%4.8789 of 5 stars2.86$118.08 -0.2%29Positive News3.65%REGNRegeneron Pharmaceuticals$576.42+0.7%4.7565 of 5 stars2.79$817.88 41.9%29Trending NewsAnalyst ForecastAnalyst Revision3.50%ALNYAlnylam Pharmaceuticals$470.27+0.2%4.0131 of 5 stars2.82$457.08 -2.8%28Trending NewsAnalyst ForecastAnalyst Revision2.60%AZNAstraZeneca$84.83-0.3%2.7739 of 5 stars2.80$86.00 1.4%51.96%INSMInsmed$163.54+1.3%2.981 of 5 stars2.86$152.88 -6.5%21Analyst Forecast1.44%ARGXargenex$815.61+0.3%3.7213 of 5 stars3.00$817.53 0.2%24Trending NewsAnalyst ForecastAnalyst Revision1.38%BIIBBiogen$143.66-1.1%4.6819 of 5 stars2.32$180.69 25.8%31Analyst ForecastAnalyst Revision1.21%UTHRUnited Therapeutics$432.19-0.3%4.3006 of 5 stars2.67$457.21 5.8%15Insider Trade1.00%INCYIncyte$88.15+2.5%4.4035 of 5 stars2.32$84.79 -3.8%190.94%SMMTSummit Therapeutics$22.64+4.1%3.0064 of 5 stars2.50$31.29 38.2%18Upcoming EarningsAnalyst UpgradeGap Up0.92%RPRXRoyalty Pharma$36.18+0.5%4.9065 of 5 stars3.20$46.00 27.1%50.92%ILMNIllumina$93.00+2.2%4.7872 of 5 stars2.15$123.56 32.9%20Trending NewsAnalyst Revision0.91%TEMTempus AI$91.91+2.3%1.6217 of 5 stars2.43$71.83 -21.8%14Gap Up0.88%MEDPMedpace$514.32-0.5%4.3244 of 5 stars1.94$424.10 -17.5%17Upcoming Earnings0.80%NBIXNeurocrine Biosciences$137.73+0.4%4.8266 of 5 stars2.80$163.44 18.7%20Positive News0.80%SNYSanofi$48.96-0.5%4.2688 of 5 stars3.00$62.67 28.0%10Analyst Revision0.73%ASNDAscendis Pharma A/S$207.12-0.8%3.2019 of 5 stars2.88$248.29 19.9%16Analyst ForecastAnalyst Revision This page (NASDAQ:BIB) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
